Switching from anti-CD20 therapies to cladribine and vice versa – Analysis of a German relapsing multiple sclerosis cohort
- DOI
- 10.1016/j.neurot.2025.e00812
- Published
- 2026-01
- Container
- Neurotherapeutics
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.neurot.2025.e00812,
title = {Switching from anti-CD20 therapies to cladribine and vice versa – Analysis of a German relapsing multiple sclerosis cohort},
author = {Franz Felix Konen and Steffen Pfeuffer and Konstantin Fritz Jendretzky and Klaus Gehring and Birte Elias-Hamp and Kurt-Wolfram Sühs and Stephan Halle and Korbinian Brand and Ralf Lichtinghagen and Eline Willemse and Marc Pawlitzki and Jens Kuhle and Sven G. Meuth and Christoph Kleinschnitz and Refik Pul and Thomas Skripuletz},
year = {2026},
journal = {Neurotherapeutics},
doi = {10.1016/j.neurot.2025.e00812},
url = {https://doi.org/10.1016/j.neurot.2025.e00812}
}RIS
TY - JOUR TI - Switching from anti-CD20 therapies to cladribine and vice versa – Analysis of a German relapsing multiple sclerosis cohort AU - Franz Felix Konen AU - Steffen Pfeuffer AU - Konstantin Fritz Jendretzky AU - Klaus Gehring AU - Birte Elias-Hamp AU - Kurt-Wolfram Sühs AU - Stephan Halle AU - Korbinian Brand AU - Ralf Lichtinghagen AU - Eline Willemse AU - Marc Pawlitzki AU - Jens Kuhle AU - Sven G. Meuth AU - Christoph Kleinschnitz AU - Refik Pul AU - Thomas Skripuletz PY - 2026 JO - Neurotherapeutics DO - 10.1016/j.neurot.2025.e00812 UR - https://doi.org/10.1016/j.neurot.2025.e00812 ER -
APA
Konen, F. F., Pfeuffer, S., Jendretzky, K. F., Gehring, K., Elias-Hamp, B., Sühs, K., Halle, S., Brand, K., Lichtinghagen, R., Willemse, E., Pawlitzki, M., Kuhle, J., Meuth, S. G., Kleinschnitz, C., Pul, R., & Skripuletz, T. (2026). Switching from anti-CD20 therapies to cladribine and vice versa – Analysis of a German relapsing multiple sclerosis cohort. Neurotherapeutics. https://doi.org/10.1016/j.neurot.2025.e00812
Source records
- crossref · retrieved 2026-09-25T16:34:48.802Z